4//SEC Filing
Topper James N 4
Accession 0001415889-25-018316
CIK 0001936258other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:41 PM ET
Size
9.3 KB
Accession
0001415889-25-018316
Insider Transaction Report
Form 4
Topper James N
Director
Transactions
- Purchase
Ordinary Shares
2025-06-24$18.43/sh+2,520$46,454→ 3,024,873 total(indirect: By Frazier Life Sciences X, L.P.) - Purchase
Ordinary Shares
2025-06-25$18.26/sh+1,260$23,012→ 3,026,133 total(indirect: By Frazier Life Sciences X, L.P.)
Holdings
- 3,801,000(indirect: By LLC)
Ordinary Shares
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.305 to $18.63. inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The total number of shares beneficially owned includes an additional incremental purchase of 200 shares on March 26, 2025, which was inadvertently omitted from the Form 4 filed on March 28, 2025
- [F3]The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.10 to $18.3795. inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F5]The shares are held directly by Frazier Lifesciences Sponsor LLC. The sole member of Frazier Lifesciences Sponsor LLC is Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0001341382
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 7:41 PM ET
- Size
- 9.3 KB